Hsa_circ_0119412 is a tumor promoter in hepatocellular carcinoma by inhibiting miR-526b-5p to upregulate STMN1

References

• Erratum: global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70(4):313. doi:10.3322/caac.21609
   Web of Science ®Google Scholar
• Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochimica Et Biophysica Acta (BBA) - Reviews On Cancer. 2020;1873(1):188314. doi:10.1016/j.bbcan.2019.188314.
   PubMed Web of Science ®Google Scholar
• He Y, Lu M, Che J, Chu Q, Zhang P, Chen Y. Biomarkers and future perspectives for hepatocellular carcinoma immunotherapy. Front Oncol. 2021;11:716844. doi:10.3389/fonc.2021.716844.
   PubMed Web of Science ®Google Scholar
• Shen H, Liu B, Xu J, Zhang B, Wang Y, Shi L, Cai X. Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer. J Hematol Oncol. 2021;14:134. doi:10.1186/s13045-021-01145-8.
   PubMed Web of Science ®Google Scholar
• Feng N, Guo Z, Wu X, Tian Y, Li Y, Geng Y, Yu Y. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Respir Res. 2021;22:248. doi:10.1186/s12931-021-01840-7.
   PubMed Web of Science ®Google Scholar
• Xie Y, Hang X, Xu W, Gu J, Zhang Y, Wang J, Zhang X, Cao X, Zhan J, Wang J, et al. CircFAM13B promotes the proliferation of hepatocellular carcinoma by sponging miR-212, upregulating E2F5 expression and activating the P53 pathway. Cancer Cell Int. 2021;21(1):410. doi:10.1186/s12935-021-02120-6.
   PubMed Web of Science ®Google Scholar
• Yu MC, Ding GY, Ma P, Chen YD, Zhu XD, Cai JB, Shen Y-H, Zhou J, Fan J, Sun H-C, et al. CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-myc expression. Carcinogenesis. 2021;42(10):1293–11. doi:10.1093/carcin/bgab068.
   PubMed Web of Science ®Google Scholar
• Huang T, Wang Y, Li M, Wang W, Qi Z, Li J. Circular RNA hsa_circ_0119412 contributes to tumorigenesis of gastric cancer via the regulation of the miR-1298-5p/zinc finger BED-type containing 3 (ZBED3) axis. Bioengineered. 2022;13(3):5827–5842. doi:10.1080/21655979.2022.2036406.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong F, Ren D, Ye X, Li C, Wang Y, et al. Circular RNAs function as ceRnas to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79. doi:10.1186/s12943-018-0827-8.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang D, Wang X, Liu P, Yan M. hsa_circ_0085539 promotes osteosarcoma progression by regulating miR-526b-5p and SERP1. Mol Ther Oncolytics. 2020;19:163–177. doi:10.1016/j.omto.2020.09.009.
   PubMed Web of Science ®Google Scholar
• Zhao N, Hu L, Chen H. Circ_0002762 accelerates glycolysis metabolism to promote cervical cancer progression via the miR-526b-5p/HK2 axis. Gynecol Obstet Invest. 2022;87(6):352–363. doi:10.1159/000526700.
   PubMed Web of Science ®Google Scholar
• Kong Q, Fan Q, Ma X, Li J, Ma R. CircRNA circUGGT2 contributes to hepatocellular carcinoma development via regulation of the miR-526b-5p/RAB1A axis. Cancer Manag Res. 2020;12:10229–10241. doi:10.2147/CMAR.S263985.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xiao X, Wang J, Wang Y, Yu Y. Silencing CircEIF3I/miR-526b-5p axis epigenetically targets HGF/c-met signal to hinder the malignant growth, metastasis and angiogenesis of hepatocellular carcinoma. Biochem Genet. 2023;61(1):48–68. doi:10.1007/s10528-022-10239-y.
   PubMed Web of Science ®Google Scholar
• Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, et al. High STMN1 expression is associated with cancer progression and chemo-resistance in lung squamous cell carcinoma. Ann Surg Oncol. 2017;24(13):4017–4024. doi:10.1245/s10434-017-6083-0.
   PubMed Web of Science ®Google Scholar
• Obayashi S, Horiguchi J, Higuchi T, Katayama A, Handa T, Altan B, Bai T, Bao P, Bao H, Yokobori T, et al. Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients. Int J Oncol. 2017;51(3):781–790. doi:10.3892/ijo.2017.4085.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Araki K, Yokobori T, Altan B, Ishii N, Tsukagoshi M, Kubo N, Saito F, Suzuki H, Kuwano H, et al. Stathmin 1 promotes the proliferation and malignant transformation of pancreatic intraductal papillary mucinous neoplasms. Oncol Lett. 2017;13(3):1783–1788. doi:10.3892/ol.2017.5603.
   PubMed Web of Science ®Google Scholar
• Liu X, Xie S, Zhang J, Kang Y. Long noncoding RNA XIST contributes to cervical cancer development through targeting miR-889-3p/SIX1 axis. Cancer Biother Radiopharm. 2020;35(9):640–649. doi:10.1089/cbr.2019.3318.
   PubMed Web of Science ®Google Scholar
• Zhang R, Gao X, Zuo J, Hu B, Yang J, Zhao J, Chen J. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway. Cancer Sci. 2020;111:406–417. doi:10.1111/cas.14262.
   PubMed Web of Science ®Google Scholar
• Miao L, Zhang Z, Ren Z, Li Y. Application of immunotherapy in hepatocellular carcinoma. Front Oncol. 2021;11:699060. doi:10.3389/fonc.2021.699060.
   PubMed Web of Science ®Google Scholar
• Huang Z, Xia H, Liu S, Zhao X, He R, Wang Z, Shi W, Chen W, Kang P, Su Z, et al. The mechanism and clinical significance of Circular RNAs in hepatocellular carcinoma. Front Oncol. 2021;11:714665. doi:10.3389/fonc.2021.714665.
   PubMed Web of Science ®Google Scholar
• Li P, Song R, Yin F, Liu M, Liu H, Ma S, Jia X, Lu X, Zhong Y, Yu L, et al. circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma. Mol Ther. 2022;30(1):431–447. doi:10.1016/j.ymthe.2021.08.027.
   PubMed Web of Science ®Google Scholar
• Cao H, Quan S, Zhang L, Chen Y, Jiao G. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma. Oncol Lett. 2021;21(5):391. doi:10.3892/ol.2021.12652.
   PubMed Web of Science ®Google Scholar
• Zeng X, Tan C, Mo M, Qin X, Ma X, Huang K, Wang X, Liang W, Yang L. CircRNA profiling identifies circRNF180 as a tumor suppressor in hepatocellular carcinoma. Epigenomics. 2021;13:513–530. doi:10.2217/epi-2020-0385.
   PubMed Web of Science ®Google Scholar
• Lv Y, Wang M, Chen M, Wang D, Luo M, Zeng Q. hsa_circ_0119412 overexpression promotes cervical cancer progression by targeting miR-217 to upregulate anterior gradient 2. J Clin Lab Anal. 2022;36(4):e24236. doi:10.1002/jcla.24236.
   PubMed Web of Science ®Google Scholar
• Li K, Yao T, Zhang Y, Li W, Wang Z. NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: role, mechanism and therapeutic potential. Int J Biol Sci. 2021;17(13):3428–3440. doi:10.7150/ijbs.62728.
   PubMed Web of Science ®Google Scholar
• Zhao X, Dong W, Luo G, Xie J, Liu J, Yu F. Silencing of hsa_circ_0009035 suppresses cervical cancer progression and enhances radiosensitivity through MicroRNA 889-3p-dependent regulation of HOXB7. Mol Cell Biol. 2021;41(6):e0063120. doi:10.1128/MCB.00631-20.
   PubMed Web of Science ®Google Scholar
• Liu YP, Pan LL, Kong CC. Stathmin 1 promotes the progression of liver cancer through interacting with YAP1. Eur Rev Med Pharmacol Sci. 2020;24(13):7335–7344. doi:10.26355/eurrev_202007_21900.
   PubMed Web of Science ®Google Scholar
• Hsieh SY, Huang SF, Yu MC, Yeh TS, Chen TC, Lin YJ, Chang C-J, Sung C-M, Lee Y-L, Hsu C-Y, et al. Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog. 2010;49(5):476–487. doi:10.1002/mc.20627.
   PubMed Web of Science ®Google Scholar